Current NDC auxiliary source row compounder:2373

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 73177-144
Product Ndc: 73177-144
Product Ndc Digits: 73177144
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Theophylline
Proprietary Name Suffix: [empty]
Nonproprietary Name: Theophylline
Dosage Form Name: SPRAY
Route Name: NASAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: STAQ Pharma Inc
Establishment Name: STAQ Pharma Inc
Establishment Fei: [empty]
Substance Name: THEOPHYLLINE
Active Ingredients Info: 1.55 mg/1 mL
History Active Ingredients Raw: THEOPHYLLINE
History Active Ingredients Info Raw: 1.55 mg/1 mL
History Dosage Raw: SPRAY
Dea Schedule: [empty]
Package Ndc Raw: 73177-144-31
Package Ndc: 73177-144-31
Package Ndc Digits: 7317714431
Package Ndc11: 73177014431
Package Description: 19 mL in 1 VIAL, PLASTIC (73177-144-31)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:2373
Source Row Number: 2373
Source Row Hash: 728dede1ba63051a6a03066639918de0f23c35d14971d21f573b7dc5406b1085
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01

Exact raw FDA source fields#

{
    "ROUTENAME": "NASAL",
    "PRODUCTNDC": "73177-144",
    "DEASCHEDULE": "",
    "LABELERNAME": "STAQ Pharma Inc",
    "SUBSTANCENAME": "THEOPHYLLINE",
    "DOSAGEFORMNAME": "SPRAY",
    "NDCPACKAGECODE": "73177-144-31",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Theophylline",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Theophylline",
    "PACKAGEDESCRIPTION": "19 mL in 1 VIAL, PLASTIC (73177-144-31) ",
    "ACTIVEINGREDIENTSINFO": "1.55 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:2373
Source Row Number: 2373
Status Scope: package
Lookup Ndc: 73177-144-31
Lookup Ndc Digits: 7317714431
Product Ndc: 73177-144
Product Ndc Digits: 73177144
Package Ndc: 73177-144-31
Package Ndc Digits: 7317714431
Package Ndc11: 73177014431
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 728dede1ba63051a6a03066639918de0f23c35d14971d21f573b7dc5406b1085
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01